Share This Page
Details for Patent: D396911
✉ Email this page to a colleague
Summary for Patent: D396911
Title: | Liquid applicator body |
Abstract: | |
Inventor(s): | DeHavilland; Lesley M. (Olathe, KS) |
Assignee: | Medi-Flex Hospital Products, Inc. (Overland Park, KS) |
Application Number: | D/071,741 |
Patent Claim Types: see list of patent claims | Delivery; |
Patent landscape, scope, and claims: | Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis IntroductionWhen navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims, the patent examination process, and the broader patent landscape, using the context of a hypothetical U.S. patent (e.g., US Patent D396911) to illustrate key points. What are Patent Claims?Patent claims are the heart of a patent application, defining the scope of the invention and the protection it seeks. These claims must be clear, concise, and supported by the description provided in the patent application[2]. Types of Patent ClaimsPatent claims can be categorized into several types:
The Patent Examination ProcessThe journey to obtaining a U.S. patent involves a rigorous examination process. Filing the Patent ApplicationThe applicant files a patent application with the United States Patent and Trademark Office (USPTO), which includes the claims, a detailed description, and any necessary drawings. Office Actions and ResponsesAfter filing, the application is reviewed by a patent examiner. If the examiner finds issues with the application, an Office Action is issued, detailing the rejections or objections. The applicant must respond to these issues by addressing each rejection or objection specifically and making any necessary amendments to the claims[2]. Allowance and IssueIf the examiner determines that the claims are allowable, a Notice of Allowance and Fee(s) Due is sent to the applicant. Upon payment of the issue fees, the patent is granted[2]. Measures of Patent Allowance RatesUnderstanding the likelihood of a patent being granted involves several metrics: First-Action Allowance RateThis is the proportion of applications allowed without further examination after the initial review[1]. Progenitor Allowance RateThis rate reflects the proportion of progenitor applications (those not related to any previously filed U.S. patent applications) that are allowed without any continuation procedures[1]. Family Allowance RateThis measures the proportion of progenitor applications that result in at least one patent, including outcomes from continuation applications[1]. Continuation ProceduresContinuation procedures allow applicants to modify or expand their original application:
Patent Scope and LandscapeTechnology FieldsPatents are categorized into various technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous “Other” category. This categorization helps in analyzing trends and patterns in patenting activity[1]. Geographic and Economic AnalysisPatent data can be analyzed by geographic location and economic sector. For instance, patents can be mapped to the residence of the inventor or the sector of the owner, providing insights into innovation hotspots and industry trends[4]. Patent Claims Research DatasetThe USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset helps in understanding patent scope and trends through parsed claims text and claim-level statistics[3]. Case Studies and Legal PrecedentsReal-world cases illustrate the complexities of patent claims and their interpretation. Lite-Netics LLC v. Nu Tsai Capital LLCIn this case, the Federal Circuit Court of Appeals addressed the interpretation of patent claims, particularly the claim construction and the doctrine of equivalents. The court emphasized that claim terms must be given the meaning that the specification and prosecution history suggest, highlighting the importance of precise claim drafting and interpretation[5]. Key Takeaways
FAQsWhat is the primary purpose of patent claims in a patent application?The primary purpose of patent claims is to define the scope of the invention and the protection it seeks. How long does a U.S. patent typically last?A U.S. patent generally lasts for 20 years from the filing date of the patent application. What is the difference between a continuation and a continuation-in-part (CIP)?A continuation allows the applicant to continue the examination process based on the original application, while a CIP permits the introduction of new subject matter. How are patent claims interpreted in legal disputes?Patent claims are interpreted based on the specification, prosecution history, and relevant case law, ensuring that the meaning given to claim terms is consistent with these sources. What is the significance of the Patent Claims Research Dataset?The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, helping in the analysis of patent scope and trends. Sources
More… ↓ |
Drugs Protected by US Patent D396911
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |